Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Non-Muscle Invasive Bladder Neoplasms
×
durvalumab
×
Clear all
Filters
3
NCT03528694
2026-04-14
POTOMAC
AstraZeneca
Phase 3
Active not recruiting
1,018 enrolled
NCT05943106
2026-03-11
PATAPSCO
AstraZeneca
Phase 3
Active not recruiting
100 enrolled